
Pharma Business Development & Licensing Course
Master the full spectrum of pharmaceutical business development, from asset valuation and due diligence to deal structuring and alliance management. This course equips BD professionals with the analytical frameworks, negotiation strategies, and governance tools used at top pharma companies. Whether you are evaluating your first licensing deal or managing a multi-asset portfolio, you will gain the skills to drive real pipeline value.
What you will learn:
This course covers every stage of the pharmaceutical BD and licensing process, starting with drug development fundamentals and industry landscape analysis. You will learn how to value assets using rNPV models, conduct scientific and clinical due diligence, and source and screen external opportunities systematically. You will study how to structure licensing agreements, draft term sheets, and negotiate complex multi-party deals with confidence. The curriculum also addresses alliance management, portfolio strategy, regulatory considerations, IP fundamentals, and emerging deal structures including digital health and advanced therapeutic modalities. By the end, you will be equipped to contribute strategically to BD decisions at any stage of the pharmaceutical pipeline.
How you study in practice Pharma Business Development & Licensing Course
How you practise Pharma Business Development & Licensing Course
For businesses looking to train their team
With Dedika for businesses, the course includes exercises and examples tailored to your own business and the way your company needs.
Course content
8 Chapters • 38 LessonsDuration between 4 and 360 hours (you decide)
Chapter 1HideHide detailsSee detailsFoundations of Pharma Business Development
Foundations of Pharma Business Development
Lesson 1 • Role of Business Development
Defines BD scope, distinguishing it from sales and marketing. Connects BD activities to corporate strategy and pipeline growth objectives.
Lesson 2 • The Pharma Industry Landscape
Covers industry structure, key stakeholders, and market dynamics shaping BD decisions. Provides context for all subsequent deal-making and licensing concepts.
Lesson 3 • Drug Development Lifecycle Essentials
Summarises discovery through commercialisation stages relevant to deal timing. Enables BD professionals to assess asset maturity and risk profiles.
Lesson 4 • Strategic Rationale for Partnerships
Examines why companies pursue external innovation and collaboration. Links partnership rationale to portfolio strategy and resource constraints.
Chapter 2HideHide detailsSee detailsAsset Valuation and Financial Fundamentals
Asset Valuation and Financial Fundamentals
Lesson 1 • Peak Sales and Market Sizing
Develops bottom-up and top-down market sizing methodologies for drug assets. Directly feeds revenue assumptions into valuation models.
Lesson 2 • Core Financial Concepts for BD
Introduces time value of money, cash flow modelling, and financial metrics essential for deal assessment. Grounds subsequent valuation techniques in financial theory.
Lesson 3 • Comparable Transaction Analysis
Uses precedent deals to benchmark valuation assumptions and deal terms. Teaches systematic database research and comparables selection.
Lesson 4 • Risk-Adjusted NPV Modelling
Applies probability of technical and regulatory success to NPV calculations. Produces rNPV models that reflect real-world asset uncertainty.
Lesson 5 • Deal Economics and Value Sharing
Analyses how deal structures allocate value between licensor and licensee. Connects financial modelling outputs to negotiation positioning.
Chapter 3HideHide detailsSee detailsOpportunity Identification and Screening
Opportunity Identification and Screening
Lesson 1 • Sourcing External Opportunities
Maps channels for discovering licensing and partnership opportunities. Builds a proactive sourcing capability beyond inbound deal flow.
Lesson 2 • Initial Screening and Triage
Applies rapid filters to prioritise opportunities for deeper evaluation. Prevents resource waste on poor-fit assets early in the funnel.
Lesson 3 • Strategic Fit and Portfolio Criteria
Defines criteria linking external opportunities to internal portfolio gaps. Ensures screening decisions are anchored to corporate strategy.
Lesson 4 • Building a BD Opportunity Pipeline
Establishes systems for tracking, managing, and reporting the opportunity funnel. Connects pipeline management to BD team performance metrics.
Chapter 4HideHide detailsSee detailsScientific and Clinical Due Diligence
Scientific and Clinical Due Diligence
Lesson 1 • Clinical Data Review and Interpretation
Evaluates trial design, endpoints, safety signals, and efficacy data from clinical packages. Connects clinical findings to regulatory and commercial risk.
Lesson 2 • Due Diligence Process Design
Structures the end-to-end due diligence workflow, team composition, and timeline. Sets the operational foundation for all subsequent diligence activities.
Lesson 3 • Competitive Landscape Analysis
Maps the treatment landscape and pipeline competition to assess differentiation potential. Informs go/no-go recommendations and deal valuation.
Lesson 4 • Evaluating Preclinical Data Packages
Assesses mechanism of action, in vitro and in vivo data quality, and translational relevance. Identifies scientific risks before clinical investment decisions.
Lesson 5 • Synthesising Diligence Findings
Integrates scientific, clinical, and competitive findings into a coherent risk-benefit summary. Prepares the BD team to present recommendations to decision-makers.
Chapter 5HideHide detailsSee detailsLicensing Deal Structures and Term Sheets
Licensing Deal Structures and Term Sheets
Lesson 1 • Term Sheet Drafting and Review
Applies deal structure knowledge to drafting and critiquing term sheets. Bridges conceptual understanding to practical document preparation.
Lesson 2 • Core Financial Deal Terms
Details upfront fees, milestones, royalties, and minimum payments as deal components. Builds ability to construct and evaluate financial term packages.
Lesson 3 • Types of Licensing Arrangements
Distinguishes exclusive, non-exclusive, co-exclusive, and sub-licensable licences. Connects licence type selection to strategic and commercial objectives.
Lesson 4 • Alternative Deal Structures
Explores co-development, co-promotion, option agreements, and asset acquisitions. Expands the BD professional's toolkit beyond standard licensing.
Lesson 5 • Non-Financial Deal Terms
Examines governance, diligence obligations, IP ownership, and termination provisions. Ensures students recognise how non-financial terms affect deal value.
Chapter 6HideHide detailsSee detailsNegotiation Strategy and Execution
Negotiation Strategy and Execution
Lesson 1 • Managing the Negotiation Process
Addresses meeting management, documentation, and momentum maintenance across sessions. Ensures negotiations progress efficiently towards closure.
Lesson 2 • Negotiation Preparation and Planning
Establishes pre-negotiation analysis including BATNA, priorities, and counterparty profiling. Preparation quality directly determines negotiation outcomes.
Lesson 3 • Negotiation Tactics and Techniques
Covers anchoring, concession sequencing, packaging, and value creation tactics. Equips students to navigate competitive and collaborative negotiation dynamics.
Lesson 4 • Cross-Cultural Negotiation Dynamics
Identifies cultural variables affecting communication, trust, and decision-making in global deals. Prepares students for international licensing negotiations.
Lesson 5 • Closing and Post-Negotiation Steps
Covers final agreement confirmation, handoff to legal, and relationship transition. Ensures deal closure translates into effective partnership launch.
Chapter 7HideHide detailsSee detailsAlliance Management and Partnership Governance
Alliance Management and Partnership Governance
Lesson 1 • Alliance Evolution and Termination
Manages partnership restructuring, expansion, and orderly termination scenarios. Ensures BD professionals can navigate the full alliance lifecycle.
Lesson 2 • Managing Alliance Conflict
Identifies sources of partnership conflict and applies structured resolution approaches. Preserves relationship value while protecting contractual rights.
Lesson 3 • Governance Structures and Decision Rights
Designs committee hierarchies, voting mechanisms, and escalation pathways for joint decisions. Clarifies authority to prevent operational gridlock.
Lesson 4 • Performance Monitoring and Reporting
Tracks milestone progress, financial obligations, and diligence commitments across the alliance. Enables early detection of performance gaps.
Lesson 5 • Alliance Launch and Onboarding
Establishes joint governance bodies, communication protocols, and shared workplans at deal inception. A strong launch prevents misalignment and conflict later.
Chapter 8HideHide detailsSee detailsAdvanced BD Strategy and Portfolio Management
Advanced BD Strategy and Portfolio Management
Lesson 1 • Measuring BD Function Performance
Defines KPIs and metrics for evaluating BD team effectiveness and deal quality. Enables data-driven improvement of the BD function over time.
Lesson 2 • Corporate Development and M&A Interface
Clarifies the boundary and collaboration between BD licensing and M&A functions. Prepares BD professionals to contribute to acquisition processes.
Lesson 3 • Managing a Multi-Deal BD Portfolio
Addresses simultaneous management of multiple active deals and alliances. Develops prioritisation and resource management skills for BD leaders.
Lesson 4 • Portfolio Strategy and BD Alignment
Links BD deal-making to portfolio-level objectives including balance, risk, and return. Ensures individual deals serve the broader strategic portfolio plan.
Lesson 5 • Build, Buy, Partner Decision Framework
Applies structured criteria to choose between internal development, acquisition, and licensing. Integrates financial, strategic, and operational factors into the decision.
Your valid completion certificate
This course is for you:
BD analysts: ready to move from support tasks to owning deals independently.
Research scientists: exploring a transition into licensing or partnership roles.
Corporate strategy professionals: expanding their scope into pharma deal-making.
Regulatory affairs specialists: seeking to broaden their commercial and strategic impact.
Biotech founders: needing to negotiate licensing terms with larger pharma partners.
Management consultants: advising life sciences clients on transactions and partnerships.
What our students say
Your lessons are perfect. I purchased the one-year package and finally have the opportunity to follow various topics of interest without needing to change platforms... I'm grateful for everything you do, I've already recommended you to other people...

I like how the lessons are straight to the point and how I can change chapters and skip content I don't need.

I like the content and the way videos are presented and transcribed, which speeds up the process!

The platform is fast and simple to use. The diversity of content and complementary videos really help with learning.

Top qualifications
FAQ
Who is Dedika?
Is the certificate valid in the United Kingdom?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course




















